Stocks Health care PRAX
NASDAQ · Health carePraxis Precision Medicines, Inc. (PRAX)
It posted a net loss of $339.1M. In fiscal 2025 capital spending exceeded operating cash flow by $249.1M. At June 30, 2026 it held $474.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Praxis Precision Medicines, Inc. does
Praxis Precision Medicines, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PRAX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$303.3M | -$13.48 | -$249.1M |
| 2024 | $8.6M | -$182.8M | -$10.21 | -$131.8M |
| 2023 | $2.4M | -$123.3M | -$18.69 | -$111.2M |
| 2022 | $0 | -$214M | -$69.65 | -$185.5M |
| 2021 | n/a | -$167.1M | -$59.14 | -$125.6M |
| 2020 | n/a | -$61.8M | -$117.98 | -$52.6M |
Latest SEC filings
What Praxis Precision Medicines, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 7, 2026Other event 8-K
- July 2, 2026Auditor change 8-K
- June 29, 2026Other event 8-K
- June 22, 2026Other event 8-K
- June 12, 2026
- June 1, 2026Other event 8-K
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about PRAX
What does Praxis Precision Medicines, Inc. do?
Praxis Precision Medicines, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PRAX.
Is Praxis Precision Medicines, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $339.1M.
When did Praxis Precision Medicines, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from August 14, 2026.
Similar companies
Follow PRAX
Get an email when Praxis Precision Medicines, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PRAX: get an email when it filesWhere the numbers come from
Financial figures are the values Praxis Precision Medicines, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.